Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/29/2003EP1240357A4 Incrementally truncated nucleic acids and methods of making same
10/29/2003EP1019528B1 Method for assaying proteolytic enzymes using fluorescence-quenched substrates
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP0951553B1 Adenovirus e4 proteins for inducing cell death
10/29/2003EP0946736B1 Method for expression of heterologous proteins in yeast
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0920522B1 A vector for polynucleotide vaccines
10/29/2003EP0920501B1 Neuritin, a neurogene
10/29/2003EP0915911B1 Parathyroid hormone analogues for the treatment of osteoporosis
10/29/2003EP0835129B1 Prevention of a disease having the characteristics of diabetes
10/29/2003EP0832121B1 Methods for purifying authentic igf from yeast hosts
10/29/2003EP0763105B1 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
10/29/2003EP0745128B1 Hepatitis b virus mutants, reagents and methods for detection
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0682710B1 Isolation process using immobilized proteins with specific binding capacities
10/29/2003EP0627000B1 Mammalian expression systems for hcv proteins
10/29/2003EP0602193B1 Enhanced expression in plants
10/29/2003EP0546118B1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003EP0293394B2 Novel thrombolytic proteins
10/29/2003CN1452659A Corynebacterium glutamicum genes encoding metabolic pathway proteins
10/29/2003CN1452658A Process for production of human interferon alpha from genetically engineered yeast
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452635A Recombinant fusion protein for diagnosis of tsutsugamushi disease
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452632A Extended native chemical ligation
10/29/2003CN1452631A Computer based method for identifying conserved invariant peptide motifs
10/29/2003CN1452493A Method for cell adhesion and wound healing
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1451752A Control of LAP-to-LIP ratio
10/29/2003CN1451749A Rice zinc finger protein gene for negative regulating plant apoptosis and promoting growth and differentiation of transgene callus
10/29/2003CN1451748A Method for preparing interferon
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/29/2003CN1125826C Hepatitis E virus gene sequence and its application
10/28/2003US6640000 Method and apparatus for analyzing images
10/28/2003US6639129 DNA sequences from photorhabdus luminescens
10/28/2003US6639128 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
10/28/2003US6639123 Melanocortin-3 receptor deficient cells, non-human trangenic animals and methods of selecting compounds which regulate body weight
10/28/2003US6639122 Transgenic swine having HLA-D gene, swine cells thereof and xenografts therefrom
10/28/2003US6639121 Transgenic mouse comprising an oncogene operably linked to a promoter that can be regulated by reverse tetracycline transactivator and doxycycline; repeatedly inducible, reducible and re-inducible by controlling transactivator
10/28/2003US6639064 NRIF3, novel co-activator for nuclear hormone receptors
10/28/2003US6639063 Signal peptide directs the secretion of a polypeptide when located at the amino terminus of a polypeptide
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639056 Antibodies specifically reactive with integrin β6 subunits
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6639054 Insecticidal proteins
10/28/2003US6639052 Human ADA2 polypeptides
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6639050 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/28/2003US6638912 Peptide compositions mimicking TGF-β activity
10/28/2003US6638911 Modulating agents comprise one or more of a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; a non-peptide mimetic of a desmosomal cadherin CAR sequence; a substance, such as an antibody or antigen binding
10/28/2003US6638910 Compositions and methods for controlling plant pests
10/28/2003US6638908 Crystals of the large ribosomal subunit
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638905 G protein-coupled corticotropin-releasing factor; for use in treatment of endocrine, gastrointestinal, reproductive, central nervous and immune disorders
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638768 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/28/2003US6638766 Promoter of the sugarcane UBI4 gene
10/28/2003US6638764 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase
10/28/2003US6638756 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/28/2003US6638749 Carbon dioxide soluble surfactant having two fluoroether CO2-philic tail groups and a head group
10/28/2003US6638741 Differentiation-suppressive polypeptide serrate-2
10/28/2003US6638740 Chromatography, elution, ion exchanging
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638735 Plasmid for gene expression in pichia ciferrii and transformation method using the same
10/28/2003US6638734 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/28/2003US6638733 G-protein coupled receptors amplified in breast cancer
10/28/2003US6638732 Mutants of Green Fluorescent Protein
10/28/2003US6638731 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of alzheimer's disease
10/28/2003US6638724 BLNK proteins
10/28/2003US6638720 Hybridization of probe as indication; transforming plants to impart resistance
10/28/2003US6638562 Fractionation of soybean 7S globulin and 11S globulin and process for producing the same
10/28/2003US6638552 Wheat flour from plant comprising recombinant expression cassette comrising a nucleic acid encoding polypeptide and seed-specific promoter
10/28/2003US6638531 Peptide antibiotics for resistant bacteria; fungicides
10/28/2003US6638518 Administering microbial or Mycobacterial polypeptide as antiasthmatic agent
10/28/2003US6638517 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638510 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
10/28/2003US6638506 Detecting for mononucleic cells
10/28/2003US6638504 Methods for treating cancer
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638271 Multiple beam laser sculpting system and method
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2095109C Process for production of exogenous gene or its product in plant cells
10/28/2003CA2090005C Cross-reactive influenza a immunization
10/28/2003CA2058020C Short peptides with insulin activity
10/26/2003CA2425886A1 Root-specific conifer gene promoter and its use
10/23/2003WO2003087841A2 An ephrin-b receptor protein involved in carcinoma
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087836A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087815A2 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
10/23/2003WO2003087769A2 Method for identifying modulators of ion channels
10/23/2003WO2003087762A2 Methyl-cpg binding domain protein 2 homologs
10/23/2003WO2003087758A2 Peptides for detection of antibody to a. phagocytophila
10/23/2003WO2003087757A2 Particle-bound human immunodeficiency virus envelope clycoproteins and related compositions and methods
10/23/2003WO2003087532A1 Antifreeze proteins for inhibition of clathrate hydrate formation and reformation
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
1 ... 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 ... 2916